Skip to main content
OpenTrials
Completed

NCT Number: NCT06485765

DASH Diet, Quality of Life and Cardiac Parameters of Patients With Acute Coronary Syndrome

The clinical trail study aimed to determine effect of DASH eating plan on cardiac parameters and quality of life in hypertensive individuals diagnosed with acute coronary syndrome.

The main questions it aims to answer are:

1. DASH diet improve quality of life? 2. DASH diet improve cardiac parameters?

The researchers assessed the results of 12 weeks of the DASH diet.

Patients will apply the DASH diet prepared individually by the researchers for 12 weeks.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Acute Coronary Syndrome Cardiovascular Diseases Heart Diseases Hypertension Myocardial Ischemia Vascular Diseases

Age range

19 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Bandırma Onyedi Eylul University

Balıkesir, Bandırma, 10200, Turkey (Türkiye)

About this study

The study period was 12 weeks. Patients' food consumption (3 day), anthropometric measurements, blood pressure measurements, physical activity levels, biochemical and cardiac parameters, adherence to DASH eating plan and the MacNew Heart Health-Related Quality of Life Scale were recorded at the beginning of the study and at the end of 12 weeks.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • diagnosed with acute coronary syndrome within the last month
  • with a measured blood pressure above 140/90 mmHg or using antihypertensive drugs
  • not obese (body mass index < 30)
  • not diagnosed with a disease requiring a different medical nutrition therapy (chronic renal failure, diabetes, cancer, etc.)
  • volunteered to participate in the study

Exclusion criteria

  • Acute coronary syndrome diagnosed more than 1 month ago
  • obese (body mass index > 30 )
  • without hypertension
  • receiving different medical nutrition therapy

Treatment and study plan

Diet planning

Other

Healthy eating planning

Primary outcomes

  1. Quality of Life (MacNew Heart Disease Health-Related Quality of Life Scale)

    Time frame: 12 week

    The quality of life of the patients at the beginning of the study and at the end of the 12th week was assessed with the MacNew Heart Disease Health-Related Quality of Life Scale. The scale is a different form of the Post-MI Quality of Life Scale, which was developed to determine especially depression and anxiety in patients with acute MI (Myocardial Infarction) and which can be evaluated by patients responding to the scale. The scale can be used in different cardiac patients such as MI, angina pectoris and heart failure patients and there is a high correlation between it and other tools that assess quality of life. MacNew Heart Disease Health-Related Quality of Life Scale consists of three sub-dimensions (emotional, physical and social) and 27 items in 7-point Likert type. The answer to each item is between 1-7. A low score indicates poor quality of life, while a high score indicates better quality of life.

  2. Ejection Fraction (%)

    Time frame: 12 weeks

    A measurement of the percentage of blood leaving the heart each time it squeezes (using echocardiographic imaging)

Sponsors and collaborators

Lead sponsor

Bandırma Onyedi Eylül University

Other

Registry information

Official study title

The Effect of the DASH (Dietary Approaches to Stop Hypertension) Diet on Quality of Life and Cardiac Parameters in Patients Acute Coronary Syndrome With Hypertension

Important dates

Study start
2020
Primary completion
2020
Study completion
2021
First posted
Jul 3, 2024
Registry last updated
Jul 3, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.